-
1
-
-
0000657364
-
Emerging concept of poliomyelitis infection
-
Bodian D. Emerging concept of poliomyelitis infection. Science 1955; 122:105-8.
-
(1955)
Science
, vol.122
, pp. 105-108
-
-
Bodian, D.1
-
2
-
-
0026075384
-
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review
-
Patriarca PA,Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991; 13:926-39.
-
(1991)
Rev Infect Dis
, vol.13
, pp. 926-939
-
-
Patriarca, P.A.1
Wright, P.F.2
John, T.J.3
-
3
-
-
77951918630
-
Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination
-
Grassly NC, Jafari H, Bahl S, et al. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis 2010; 201:1535-43.
-
(2010)
J Infect Dis
, vol.201
, pp. 1535-1543
-
-
Grassly, N.C.1
Jafari, H.2
Bahl, S.3
-
4
-
-
0000551263
-
Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection
-
Ogra PL, Karzon DT, Righthand F, MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med 1968; 279: 893-900.
-
(1968)
N Engl J Med
, vol.279
, pp. 893-900
-
-
Ogra, P.L.1
Karzon, D.T.2
Righthand, F.3
MacGillivray, M.4
-
5
-
-
0025977851
-
Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines
-
Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis 1991; 163:1-6.
-
(1991)
J Infect Dis
, vol.163
, pp. 1-6
-
-
Onorato, I.M.1
Modlin, J.F.2
McBean, A.M.3
Thoms, M.L.4
Losonsky, G.A.5
Bernier, R.H.6
-
6
-
-
0027857937
-
The elimination of polio in the Scandinavian countries
-
Böttiger M. The elimination of polio in the Scandinavian countries. Public Health Rev 1993-1994; 21:27-33.
-
(1993)
Public Health Rev
, vol.21
, pp. 27-33
-
-
Böttiger, M.1
-
7
-
-
34247115561
-
Randomized placebo-controlled trial of inactivated poliovirus vaccine in Cuba
-
Cuba IPV Study Collaborative Group
-
Cuba IPV Study Collaborative Group. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med 2007; 356:1536-44.
-
(2007)
N Engl J Med
, vol.356
, pp. 1536-1544
-
-
-
8
-
-
84873048082
-
Priming after a fractional dose of inactivated poliovirus vaccine
-
Resik S, Tejeda A, Sutter RW, et al. Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med 2013; 368:416-24.
-
(2013)
N Engl J Med
, vol.368
, pp. 416-424
-
-
Resik, S.1
Tejeda, A.2
Sutter, R.W.3
-
10
-
-
84861213998
-
Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge
-
Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog 2012; 8:e1002599.
-
(2012)
PLoS Pathog
, vol.8
-
-
Hird, T.R.1
Grassly, N.C.2
-
11
-
-
77953938095
-
Fractional doses of inactivated poliovirus vaccine in Oman
-
Mohammed AJ, AlAwaidy S, Bawikar S, et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl Med 2010; 362: 2351-9.
-
(2010)
N Engl Med
, vol.362
, pp. 2351-2359
-
-
Mohammed, A.J.1
Alawaidy, S.2
Bawikar, S.3
-
12
-
-
34250971354
-
50% end-point calculation
-
Karber G. 50% end-point calculation. Arch Exp Pathol Pharmak 1931; 162:480-3.
-
(1931)
Arch Exp Pathol Pharmak
, vol.162
, pp. 480-483
-
-
Karber, G.1
-
13
-
-
0037090066
-
Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population
-
Herremans T, Kimman TG, Conyn-Van Spaendonck MA, et al. Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population. Clin Infect Dis 2002; 34:1067-75.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1067-1075
-
-
Herremans, T.1
Kimman, T.G.2
Conyn-Van Spaendonck, M.A.3
-
14
-
-
80455179632
-
Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum
-
Arita M, Iwai M, Wakita T, Shimizu H. Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum. Clin Vaccine Immunol 2011; 18:1889-94.
-
(2011)
Clin Vaccine Immunol
, vol.18
, pp. 1889-1894
-
-
Arita, M.1
Iwai, M.2
Wakita, T.3
Shimizu, H.4
-
15
-
-
84867472665
-
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
-
Brown EP, Licht AF, Dugast AS, et al. High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples. J Immunol Methods 2012; 386:117-23.
-
(2012)
J Immunol Methods
, vol.386
, pp. 117-123
-
-
Brown, E.P.1
Licht, A.F.2
Dugast, A.S.3
-
16
-
-
0032906950
-
Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian Authority
-
Manor Y, Handsher R, Halmut T, et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian Authority. J Clin Microbiol 1999; 37:1670-5.
-
(1999)
J Clin Microbiol
, vol.37
, pp. 1670-1675
-
-
Manor, Y.1
Handsher, R.2
Halmut, T.3
-
17
-
-
16944366445
-
Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman, and Thailand
-
WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines
-
WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. J Infect Dis 1997; 175S1:S215-27.
-
(1997)
J Infect Dis
, Issue.175
-
-
-
18
-
-
33750277766
-
Quantitative analysis of poliomyelitis like paralysis in mice induced by a replicon
-
Arita M, Nagata N, Sata T, Miyamura T, Shimizu H. Quantitative analysis of poliomyelitis like paralysis in mice induced by a replicon. J Gen Virol 2006; 87:3317-27.
-
(2006)
J Gen Virol
, vol.87
, pp. 3317-3327
-
-
Arita, M.1
Nagata, N.2
Sata, T.3
Miyamura, T.4
Shimizu, H.5
-
19
-
-
0344941364
-
Homologous and heterologous resistance to rhinovirus common cold
-
Fleet WF, Couch RB, Cate TR, Knight V. Homologous and heterologous resistance to rhinovirus common cold. Amer J Epid 1965; 82: 185-96.
-
(1965)
Amer J Epid
, vol.82
, pp. 185-196
-
-
Fleet, W.F.1
Couch, R.B.2
Cate, T.R.3
Knight, V.4
-
20
-
-
0023279924
-
Candidate rotavirus vaccine (rhesus rotavirus strain) in children: An evaluation
-
Wright PF, Tajima T, Thompson J, Kokubun K, Kapikian A, Karzon DT. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation. Pediatrics 1987; 80:473-80.
-
(1987)
Pediatrics
, vol.80
, pp. 473-480
-
-
Wright, P.F.1
Tajima, T.2
Thompson, J.3
Kokubun, K.4
Kapikian, A.5
Karzon, D.T.6
-
21
-
-
0018419277
-
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection
-
McIntosh K, McQuillin J, Gardner PS. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun 1979; 23:276-81.
-
(1979)
Infect Immun
, vol.23
, pp. 276-281
-
-
McIntosh, K.1
McQuillin, J.2
Gardner, P.S.3
-
22
-
-
0028812410
-
Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval
-
Cohen-Abbo A, Culley BS, Reed GW, et al. Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval. Pediatr Infect Dis J 1995; 14:100-6.
-
(1995)
Pediatr Infect Dis J
, vol.14
, pp. 100-106
-
-
Cohen-Abbo, A.1
Culley, B.S.2
Reed, G.W.3
-
23
-
-
16944367385
-
Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group
-
Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group. J Infect Dis 1997; 175S1:S228-34.
-
(1997)
J Infect Dis
, vol.175
-
-
Modlin, J.F.1
Halsey, N.A.2
Thoms, M.L.3
Meschievitz, C.K.4
Patriarca, P.A.5
-
24
-
-
9644268227
-
Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains
-
Minor PD, Dunn G, Ramsay ME, Brown D. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains. J Med Virol 2005; 75:153-60.
-
(2005)
J Med Virol
, vol.75
, pp. 153-160
-
-
Minor, P.D.1
Dunn, G.2
Ramsay, M.E.3
Brown, D.4
-
25
-
-
0027491318
-
Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine
-
Abraham R, Minor P, Dunn G, Modlin JF, Ogra PL. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. J Infect Dis 1993; 168:1105-9.
-
(1993)
J Infect Dis
, vol.168
, pp. 1105-1109
-
-
Abraham, R.1
Minor, P.2
Dunn, G.3
Modlin, J.F.4
Ogra, P.L.5
-
26
-
-
69249202547
-
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine
-
van der Sanden S, Pallansch MA, van de Kassteele J, et al. Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine. J Virol 2009; 83:8693-704.
-
(2009)
J Virol
, vol.83
, pp. 8693-8704
-
-
Van Der Sanden, S.1
Pallansch, M.A.2
Van De Kassteele, J.3
|